Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
HOUSTON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported third-quarter 2022 results and provided the following...
-
HOUSTON, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities...
-
HOUSTON, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and...
-
Presentation highlights a greater than 60% reduction in acute exacerbations and need for antibiotics for chronic sinusitis patients who used XHANCE in landmark ReOpen phase 3 clinical trial program ...
-
TULSA, Okla., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Shannon Habermehl has been named the new executive director of Commercial Strategies for BOK Financial. In this role, Habermehl will be responsible...
-
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Antibacterial Coatings Market for Medical Implants By Material, By Type: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been...
-
HOUSTON, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and...
-
HOUSTON, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities...
-
Paris, le 21 septembre 2022, 19h30 - Ecoslops, la cleantech qui fait entrer le pétrole dans l’économie circulaire, annonce ses résultats non audités pour le premier semestre de l’exercice en cours,...
-
YARDLEY, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...